Avanos Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2011
Revenue	673.3	684.1	587	714.8	697.6	Upgrade
Revenue Growth (YoY)	-1.58%	16.54%	-17.88%	2.47%	6.94%	Upgrade
Cost of Revenue	293.6	289.9	287.8	343.9	295.4	Upgrade
Gross Profit	379.7	394.2	299.2	370.9	402.2	Upgrade
Selling, General & Admin	335	326.5	285.3	332.6	399.1	Upgrade
Research & Development	27.2	29.2	30.6	34.9	37.7	Upgrade
Operating Expenses	362.2	355.7	315.9	367.5	436.8	Upgrade
Operating Income	17.5	38.5	-16.7	3.4	-34.6	Upgrade
Interest Expense / Income	15	10	3.3	15.6	15	Upgrade
Other Expense / Income	62.3	-27.2	-15.1	50.7	14.4	Upgrade
Pretax Income	-59.8	55.7	-4.9	-62.9	-64	Upgrade
Income Tax	2	5.2	-11.2	-33.9	-18.1	Upgrade
Net Income	-61.8	50.5	6.3	-29	-45.9	Upgrade
Net Income Growth	-	701.59%	-	-	-	Upgrade
Shares Outstanding (Basic)	46	46	48	48	48	Upgrade
Shares Change	-0.15%	-3.51%	0.74%	-0.20%	1.06%	Upgrade
EPS (Basic)	-1.32	1.08	0.13	-0.61	-0.96	Upgrade
EPS (Diluted)	-1.32	1.07	0.13	-0.61	-0.96	Upgrade
EPS Growth	-	723.08%	-	-	-	Upgrade
Free Cash Flow	14.6	71.6	66.3	-22.7	-125.1	Upgrade
Free Cash Flow Per Share	0.31	1.54	1.38	-0.47	-2.61	Upgrade
Gross Margin	56.39%	57.62%	50.97%	51.89%	57.65%	Upgrade
Operating Margin	2.60%	5.63%	-2.84%	0.48%	-4.96%	Upgrade
Profit Margin	-9.18%	7.38%	1.07%	-4.06%	-6.58%	Upgrade
Free Cash Flow Margin	2.17%	10.47%	11.29%	-3.18%	-17.93%	Upgrade
Effective Tax Rate	-	9.34%	-	-	-	Upgrade
EBITDA	1.3	113.4	36.7	-4.4	-12.1	Upgrade
EBITDA Margin	0.19%	16.58%	6.25%	-0.62%	-1.73%	Upgrade
Depreciation & Amortization	46.1	47.7	38.3	42.9	36.9	Upgrade
EBIT	-44.8	65.7	-1.6	-47.3	-49	Upgrade
EBIT Margin	-6.65%	9.60%	-0.27%	-6.62%	-7.02%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).